VivoSeq
Other

PET/MRI

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

PET/MRI is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

33/100

Attrition Rate

40/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Withdrawn1 · 20%
Completed1 · 20%
Recruiting1 · 20%
Active, not recruiting1 · 20%
Terminated1 · 20%

Clinical Trials

Trial Activity

68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO)
Withdrawn·—·Phase 3·NCT04139395
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
Completed·SStanford University·Phase 2·NCT03125629·53 enrolled
Study of 18F-FFNP Breast PET/MRI
Recruiting·UUniversity of Wisconsin, Madison·Phase 2·NCT06086704·53 enrolled
FAZA PET/MRI Pancreas
Active, not recruiting·UUniversity Health Network, Toronto·N/A·NCT04395469·20 enrolled
PET/MRI Imaging of Glutamate Release in the Brain
Terminated·UUniversity of Zurich·Phase 2·NCT02511691·10 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)